Oppenheimer Price Target Adjusted To Over +300% Of Current Price
17 Août 2022 - 10:00PM
AllPennyStocks.com
A Salt Lake City-based biotech company found
tremendous success on Wednesday after Oppenheimer adjusted its
price target to $17.00 from $16.00. While this $1 move
isn’t...
To read the full story on AllPennyStocks.com, click
here.
Clene (NASDAQ:CLNN)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Clene (NASDAQ:CLNN)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024